Netherlands· NL-30a12be98f80
Procysbi 75 mg, maagsapresistent granulaat
A mercaptamine product containing mercaptaminewaterstoftartraat, registered in Netherlands by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Mercaptamine · ATC A16AA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mercaptamine costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mercaptamine · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$589.95
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MERCAPTAMINEWATERSTOFTARTRAAT
- Manufacturer
- Chiesi Farmaceutici S.p.A.
- Country
- Netherlands (NL)
- ATC code
- A16AA04
- ATC class
- Mercaptamine
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/13/861
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumProcysbi 75 mgChiesi Farmaceutici
- CzechiaPROCYSBIChiesi Farmaceutici S.p.A., Parma
- FinlandPROCYSBIChiesi Farmaceutici S.p.A.
- IrelandPROCYSBI 75 mg gastro-resistant granulesChiesi Farmaceutici S.p.A.
- IcelandProcysbiChiesi Farmaceutici S.p.A.*
- PolandProcysbiChiesi Farmaceutici S.p.A.
- SwedenPROCYSBI 75 mg EnterogranulatChiesi Farmaceutici S.p.A.
- United StatesCYSTADROPSRECORDATI RARE DISEASES, INC.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3602f35-6d3d-4a0c-bb02-e9f8498cd3f9 GET /v1/drugs/b3602f35-6d3d-4a0c-bb02-e9f8498cd3f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maagsapresistent granulaat",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/procysbi-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Mercaptamine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128582",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"COPOLYMEER VAN ETHYLACRYLAAT-METHACRYLZUUR (1:1)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"NATRIUMLAURILSULFAAT",
"TALK (E 553b)",
"TRIETHYLCITRAAT (E 1505)"
],
"substances": [
"MERCAPTAMINEWATERSTOFTARTRAAT"
],
"leaflet_url": null,
"authorised_at": "2013/09/06",
"procedure_number": "EMEA/H/C/002465",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/13/861",
"additional_monitoring": "N"
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.